Is there a role for mesenchymal stem cells in autoimmune diseases?

Autoimmunity

Volumn 41, Issue 8, 2008, Pages 592-595

  Uccelli, Antonio ^a,b   Mancardi, Gianluigi ^a   Chiesa, Sabrina ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b Advanced Biotechnology Center   (Italy)

Author keywords

Autoimmune diseases; Bone marrow; Experimental autoimmune encephalomyelitis; Mesenchymal stem cell; Multiple sclerosis

Indexed keywords

ANTIINFLAMMATORY ACTIVITY; ARTICLE; AUTOIMMUNE DISEASE; CELL CYCLE PHASE; CELL DIFFERENTIATION; CELL GROWTH; CELL INTERACTION; CELL RENEWAL; CELL SURVIVAL; CLINICAL EFFECTIVENESS; ENCEPHALOMYELITIS; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE FUNCTION; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; SAFETY;

ANIMALS; AUTOIMMUNE DISEASES; CELL DIFFERENTIATION; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; MICE;

EID: 65449166371     PISSN: 08916934     EISSN: 1607842X     Source Type: Journal    
DOI: 10.1080/08916930802200166     Document Type: Article

References (27)

1. Bianco, P. and Gehron, RP (2000) Marrow stromal stem cells. J Clin Invest, 105:12, pp. 1663-1668.
2. Pedemonte, E., Benvenuto, F. Casazza, S. et al. (2007) The molecular signature of therapeutic mesenchymal stem cells exposes the architecture of the hematopoietic stem cell niche synapse. BMC Genomics, 8, p. 65.
3. Dominici, M., Le Blanc, K Mueller, I. et al. (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy, 8:4, pp. 315-317.
4. Pittenger, MF, Mackay, AM Beck, SC et al. (1999) Multilineage potential of adult human mesenchymal stem cells. Science, 284:5411, pp. 143-147.
5. Uccelli, A., Moretta, L. and Pistoia, V. (2006) Immunoregulatory function of mesenchymal stem cells. Eur J Immunol, 36:10, pp. 2566-2573.
6. Nauta, AJ and Fibbe, WE (2007) Immunomodulatory properties of mesenchymal stromal cells. Blood, 110:10, pp. 3499-3506.
7. Glennie, S., Soeiro, I. Dyson, PJ et al. (2005) Bone marrow mesenchymal stem cells induce division arrest anergy of activated T cells. Blood, 105:7, pp. 2821-2827.
8. Corcione, A., Benvenuto, F. Ferretti, E. et al. (2006) Human mesenchymal stem cells modulate B-cell functions. Blood, 107:1, pp. 367-372.
9. Ramasamy, R., Fazekasova, H. Lam, EW et al. (2007) Mesenchymal stem cells inhibit dendritic cell differentiation and function by preventing entry into the cell cycle. Transplantation, 83:1, pp. 71-76.
10. Spaggiari, GM, Capobianco, A. Becchetti, S. et al. (2006) Mesenchymal stem cell-natural killer cell interactions: Evidence that activated NK cells are capable of killing MSCs, whereas MSCs can inhibit IL-2-induced NK-cell proliferation. Blood, 107:4, pp. 1484-1490.
11. Meisel, R., Zibert, A. Laryea, M. et al. (2004) Human bone marrow stromal cells inhibit allogeneic T-cell responses by indoleamine 2,3-dioxygenase mediated tryptophan degradation. Blood, 103:12, pp. 4619-4621.
12. Sato, K., Ozaki, K. Oh, I. et al. (2006) Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells. Blood, 109, pp. 228-234.
13. Chabannes, D., Hill, M. Merieau, E. et al. (2007) A role for heme oxygenase-1 in the immunosuppressive effect of adult rat and human mesenchymal stem cells. Blood, 110:10, pp. 3691-3694.
14. Le Blanc, K, Rasmusson, I. Sundberg, B. et al. (2004) Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet, 363:9419, pp. 1439-1441.
15. Zappia, E., Casazza, S. Pedemonte, E. et al. (2005) Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood, 106:5, pp. 1755-1761.
16. Gerdoni, E., Gallo, B. Casazza, S. et al. (2007) Mesenchymal stem cells effectively modulate pathogenic immune response in experimental autoimmune encephalomyelitis. Ann Neurol, 61:3, pp. 219-227.
17. Phinney, DG and Prockop, DJ (2007) Concise review: Mesenchymal stem/ multipotent stromal cells: The state of transdifferentiation and modes of tissue repair-current views. Stem Cells, 25:11, pp. 2896-2902.
18. Zhang, J., Li, Y. Chen, J. et al. (2005) Human bone marrow stromal cell treatment improves neurological functional recovery in EAE mice. Exp Neurol, 195:1, pp. 16-26.
19. Uccelli, A., Pistoia, V. and Moretta, L. (2007) Mesenchymal stem cells: A new strategy for immunosuppression?. Trends Immunol, 28:5, pp. 219-226.
20. Caplan, AI (2007) Adult mesenchymal stem cells for tissue engineering versus regenerative medicine. J Cell Physiol, 213:2, pp. 341-347.
21. Parekkadan, B., van Poll, D. Suganuma, K. et al. (2007) Mesenchymal stem cell-derived molecules reverse fulminant hepatic failure. PLoS ONE, 2:9, p. e941.
22. Ortiz, LA, Dutreil, M. Fattman, C. et al. (2007) Interleukin 1 receptor antagonist mediates the antiinflammatory and antifibrotic effect of mesenchymal stem cells during lung injury. Proc Natl Acad Sci U S A, 104:26, pp. 11002-11007.
23. Togel, F., Weiss, K. Yang, Y. et al. (2007) Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury. Am J Physiol Renal Physiol, 292:5, pp. F1626-F1635.
24. Mirotsou, M., Zhang, Z. Deb, A. et al. (2007) Secreted frizzled related protein 2 (Sfrp2) is the key Akt-mesenchymal stem cell-released paracrine factor mediating myocardial survival and repair. Proc Natl Acad Sci U S A, 104:5, pp. 1643-1648.
25. Augello, A., Tasso, R. Negrini, SM et al. (2007) Cell therapy using allogeneic bone marrow mesenchymal stem cells prevents tissue damage in collagen-induced arthritis. Arthritis Rheum, 56:4, pp. 1175-1186.
26. Prockop, DJ (2007) "Stemness" does not explain the repair of many tissues by mesenchymal stem/multipotent stromal cells (MSCs). Clin Pharmacol Ther, 82:3, pp. 241-243.
27. Passweg, J. and Tyndall, A. (2007) Autologous stem cell transplantation in autoimmune diseases. Semin Hematol, 44:4, pp. 278-285.